SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling

Esophageal cancer is one of the leading malignancies worldwide, while around sixty percent of newly diagnosed cases are in China. In recent years, genome-wide sequencing studies and cancer biology studies show that Hippo signaling functions a critical role in esophageal squamous cell carcinoma (ESCC...

Full description

Bibliographic Details
Main Authors:	Aijia Zhang, Weilong Wang, Zhijun Chen, Dan Pang, Xiaofeng Zhou, Kui Lu, Jinghan Hou, Sujie Wang, Can Gao, Benjie Lv, Ziyi Yan, Zhen Chen, Jian Zhu, Lidong Wang, Ting Zhuang, Xiumin Li
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558619303392

Similar Items

SHARPIN Facilitates p53 Degradation in Breast Cancer Cells
by: Huijie Yang, et al.
Published: (2017-02-01)

Advances in the Structural and Physiological Functions of SHARPIN
by: Beiming Yu, et al.
Published: (2022-04-01)

SHARPIN Regulates Uropod Detachment in Migrating Lymphocytes
by: Jeroen Pouwels, et al.
Published: (2013-11-01)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
by: Ma Lijuan, et al.
Published: (2023-09-01)

Structural Insights into SHARPIN-Mediated Activation of HOIP for the Linear Ubiquitin Chain Assembly
by: Jianping Liu, et al.
Published: (2017-10-01)

Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system
by: Jinxin Miao, et al.
Published: (2023-10-01)

Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB
by: An Thys, et al.
Published: (2021-01-01)

Loss of function of the mouse Sharpin gene results in Peyer's patch regression.
by: Rosemarie Seymour, et al.
Published: (2013-01-01)

YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
by: Chunyan Zheng, et al.
Published: (2023-12-01)

KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma
by: Xiaozheng Sun, et al.
Published: (2021-02-01)

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2023-04-01)

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
by: Yanping Gao, et al.
Published: (2017-11-01)

Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis
by: Snehlata Kumari, et al.
Published: (2014-12-01)

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
by: James A Rickard, et al.
Published: (2014-12-01)

SHARPIN negatively associates with TRAF2-mediated NFκB activation.
by: Yanhua Liang
Published: (2011-01-01)

Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling.
by: Nicola De Franceschi, et al.
Published: (2015-01-01)

A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damages
by: Jun Young Park, et al.
Published: (2021-11-01)

Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice.
by: John P Sundberg, et al.
Published: (2020-01-01)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
by: Huixian Xin, et al.
Published: (2022-06-01)

Sharpin suppresses β1-integrin activation by complexing with the β1 tail and kindlin-1
by: Juan Gao, et al.
Published: (2019-08-01)

Development and Validation of the Predictive Model for Esophageal Squamous Cell Carcinoma Differentiation Degree
by: Yanfeng Wang, et al.
Published: (2020-10-01)

Comparison of Survival Status and Related Risk Factors of Esophageal Squamous Cell Carcinoma Patients Between High- and Low-incidence Areas of ESCC
by: HU Shoujia, et al.
Published: (2019-09-01)

SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells.
by: Zhe Wang, et al.
Published: (2012-01-01)

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
by: Zihang Mai, et al.
Published: (2022-08-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01)

Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.
by: Emilia Peuhu, et al.
Published: (2017-01-01)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
by: Zheng Lin, et al.
Published: (2022-06-01)

Lymph node metastatic patterns and its clinical significance for thoracic superficial esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2020-09-01)

Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes.
by: Sabrina Sieber, et al.
Published: (2012-01-01)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
by: Shumei Song, et al.
Published: (2020-06-01)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2021-08-01)

The significance of Hippo pathway protein expression in oral squamous cell carcinoma
by: Yusuke Amano, et al.
Published: (2024-02-01)

Gallic acid from Terminalia chebula inhibited the growth of esophageal carcinoma cells by suppressing the Hippo signal pathway
by: Gui-Li Sun, et al.
Published: (2020-11-01)

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2022-03-01)

Esophageal squamous cell carcinoma and prognosis in Taiwan
by: Ya‐Fu Cheng, et al.
Published: (2018-09-01)

Rad51 and Systemic Inflammatory Indicators as Novel Prognostic Markers in Esophageal Squamous Cell Carcinoma
by: Ning Wu MD, et al.
Published: (2024-01-01)

Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
by: Linxiu Liu, et al.
Published: (2023-04-01)

Sarcopenia Before Concurrent Chemoradiotherapy May Develop Severe Adverse Reactions in Patients with Esophageal Squamous Cell Carcinoma
by: CHEN Xiaoxia, et al.
Published: (2023-12-01)

The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
by: Fei Kong, et al.
Published: (2016-01-01)

Prediction of Survival Time of Patients With Esophageal Squamous Cell Carcinoma Based on Univariate Analysis and ASSA-BP Neural Network
by: Yanfeng Wang, et al.
Published: (2020-01-01)